Literature DB >> 1510309

In vivo isolation of Salmonella choleraesuis from porcine neutrophils.

M B Roof1, T T Kramer, J P Kunesh, J A Roth.   

Abstract

Seventy-five pigs from 4 facilities were examined for Salmonella choleraesuis by use of bacteriologic culture of feces, blood, WBC (buffy coat), mononuclear leukocytes, and neutrophils. The organism was isolated from 0 of 75 fecal samples, compared with isolation from 39 of 75 purified neutrophil preparations. Of the pigs that did not have Salmonella isolated from feces or blood, but had S choleraesuis isolated from neutrophils, 6 were further examined. These pigs from 2 groups again had culture performed at least 3 successive times to test for repeatability and to determine optimal number of neutrophils required for Salmonella isolation. These same pigs were euthanatized and necropsied. Nineteen tissue specimens from each pig were obtained for culture, but S choleraesuis was isolated only from neutrophil samples. Results indicate that neutrophils may contribute to the carrier state in pigs and should be cultured when attempting to identify S choleraesuis carrier swine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510309

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs.

Authors:  M J Kennedy; R J Yancey; M S Sanchez; R A Rzepkowski; S M Kelly; R Curtiss
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Detection and characterization of Salmonella typhimurium from a dairy herd in North Dakota.

Authors:  L K Nolan; C W Giddings; E W Boland; D J Steffen; J Brown; A Misek
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

3.  Use of an avirulent live Salmonella Choleraesuis vaccine to reduce the prevalence of Salmonella carrier pigs at slaughter.

Authors:  P Schwarz; J D Kich; J Kolb; M Cardoso
Journal:  Vet Rec       Date:  2011-09-23       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.